Skin reaction to adalimumabBEUTHIEN, W; MELLINGHOFF, H.-U; VON KEMPIS, J et al.Arthritis and rheumatism. 2004, Vol 50, Num 5, pp 1690-1692, issn 0004-3591, 3 p.Article

AdalimumabAUBIN, F; BARTHELEMY, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 842-844, issn 0151-9638, 3 p.Article

Gestion des traitements lourds. Adalimumab : Humira^® = Onerous treatments. Adalimumab : Humira^®LEVANG, J; AUBIN, F.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 10, pp 710-713, issn 0151-9638, 4 p.Article

Interstitial Granulomatous Drug Reaction to AdalimumabMARTORELL-CALATAYUD, Antonio; BALMER, Nicole; CARDENAS CARDONA, Luis Fernando et al.The American journal of dermatopathology. 2010, Vol 32, Num 4, pp 408-409, issn 0193-1091, 2 p.Article

Differential effect of drug interference in immunogenicity assaysHART, Margreet H; DE VRIEZE, Henk; WOUTERS, Diana et al.Journal of immunological methods. 2011, Vol 372, Num 1-2, pp 196-203, issn 0022-1759, 8 p.Article

Lettre d'information pour le traitement du psoriasis par l'adalimumab (Humira^®) = Information letter on treatment of psoriasis with adalimumab (Humira^®)Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 868-870, issn 0151-9638, 3 p.Article

Frequency and Effectiveness of Dose Increase of Adalimumab, Etanercept, and Infliximab in Daily Clinical PracticeBLOM, M; KIEVIT, W; KUPER, H. H et al.Arthritis care and research. 2010, Vol 62, Num 9, pp 1335-1341, issn 0893-7524, 7 p.Article

Adalimumab : In Plaque PsoriasisCROOM, Katherine F; MCCORMACK, Paul L.American journal of clinical dermatology. 2009, Vol 10, Num 1, pp 43-50, issn 1175-0561, 8 p.Article

Steroid-unresponsive neurosarcoidosis successfully treated with adalimumabMARNANE, Michael; LYNCH, Timothy; SCOTT, Jacqueline et al.Journal of neurology. 2009, Vol 256, Num 1, pp 139-140, issn 0340-5354, 2 p.Article

Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumabBONGARTZ, T; HÄRLE, P; FRIEDRICH, S et al.Arthritis and rheumatism. 2005, Vol 52, Num 1, pp 280-282, issn 0004-3591, 3 p.Article

Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centreWARREN, R. B; BROWN, B. C; LAVERY, D et al.British journal of dermatology (1951). 2010, Vol 163, Num 4, pp 859-862, issn 0007-0963, 4 p.Article

Lupus induit par l'adalimumab: une observation = Lupus induced by adalimumab: a new case reportBRET, Sandie; NUCCIO, Alexandra; ROCHE, Céline et al.Les Nouvelles dermatologiques. 2010, Vol 29, Num AVR, pp 206-208, issn 0752-5370, 3 p., CAH1Article

Marked Improvement in Nail Psoriasis during Treatment with AdalimumabIRLA, N; YAWALKAR, N.Dermatology (Basel). 2009, Vol 219, Num 4, pp 353-356, issn 1018-8665, 4 p.Article

Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanerceptVAN LÜMIG, P. P. M; LECLUSE, L. L. A; DRIESSEN, R. J. B et al.British journal of dermatology (1951). 2010, Vol 163, Num 4, pp 838-846, issn 0007-0963, 9 p.Article

Biologic Agents and Alopecia AreataKATOULIS, A. C; ALEVIZOU, A; BOZI, E et al.Dermatology (Basel). 2009, Vol 218, Num 2, pp 184-185, issn 1018-8665, 2 p.Article

Generalized interstitial granuloma annulare - response to adalimumabWERCHAU, Siegfried; ENK, Alexander; HARTMANN, Martin et al.International journal of dermatology. 2010, Vol 49, Num 4, pp 457-460, issn 0011-9059, 4 p.Article

Switching between antitumour necrosis factor alpha biologic agents -is patient weight an important consideration?DOWNS, A. M. R.British journal of dermatology (1951). 2009, Vol 160, Num 5, pp 1123-1124, issn 0007-0963, 2 p.Article

Antibodies to constant domains of therapeutic monoclonal antibodies: Anti-hinge antibodies in immunogenicity testingRISPENS, Theo; DE VRIEZE, Henk; DE GROOT, Els et al.Journal of immunological methods. 2012, Vol 375, Num 1-2, pp 93-99, issn 0022-1759, 7 p.Article

Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanerceptFIELD, S; REGAN, A. O; SHEAHAN, K et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 7, pp 795-796, issn 0307-6938, 2 p.Article

Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanerceptBISSONNETTE, Robert; BOLDUC, Chantal; POULIN, Yves et al.Journal of the American Academy of Dermatology. 2010, Vol 63, Num 2, pp 228-234, issn 0190-9622, 7 p.Article

Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque PsoriasisLECLUSE, Lidian L. A; DRIESSEN, Rieke J. B; SPULS, Phyllis I et al.Archives of dermatology (1960). 2010, Vol 146, Num 2, pp 127-132, issn 0003-987X, 6 p.Article

The effect of adalimumab on key drivers in the pathogenesis of psoriasisHENDRIKS, A. G. M; VAN DER VELDEN, H. M. J; WOLBERINK, E. A. W et al.British journal of dermatology (1951). 2014, Vol 170, Num 3, pp 571-580, issn 0007-0963, 10 p.Article

Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisationSCHOUWENBURG, Pauline A.van; DE STADT, Lotte A.van; JAN WOLBINK, Gerrit et al.Annals of the rheumatic diseases. 2013, Vol 72, Num 1, pp 104-109, issn 0003-4967, 6 p.Article

Successful Treatment of Lichen Planus with AdalimumabHOLLO, Peter; SZAKONYI, Jozsef; KISS, Dorottya et al.Acta dermato-venereologica. 2012, Vol 92, Num 4, pp 385-386, issn 0001-5555, 2 p.Article

Treatment of Recalcitrant Eosinophilic Cellulitis With AdalimumabSARIN, Kavita Y; FIORENTINO, David.Archives of dermatology (1960). 2012, Vol 148, Num 9, pp 990-992, issn 0003-987X, 3 p.Article